Product Image

Ginkgo 450 mg

Eclectic Institute
4.6
★ ★ ★ ★ ★
(407 ratings)
Ginkgo
Product Image
Score70
A straightforward whole-leaf ginkgo capsule with uncertain active strength. Missing standardization makes dose quality and value hard to judge.
How scoring works
Quantity:90 Capsule(s) • (90 servings)
Goals:
Vision Support

Score 70

A straightforward whole-leaf ginkgo capsule with uncertain active strength. Missing standardization makes dose quality and value hard to judge.
How scoring works
$23.24($0.25 per serving)
Vitacost
$ 23.24
iHerb
$ 23.24
Amazon
$ 23.24
Report prices

Analysis

The capsule provides 450 mg freeze-dried ginkgo leaf rather than a clearly standardized extract. Whole leaf preserves the simple botanical format but does not guarantee a predictable active-marker yield.

Ginkgo has a plausible circulation-related role for cognition, memory, and focus in selected users. Vision relevance remains narrow because the formula lacks macular carotenoids, retinal fats, and antioxidant minerals.

No flavone-glycoside percentage, terpene-lactone percentage, or ginkgolic-acid purity limit is supplied. A large raw-leaf number should not be treated as equivalent to a smaller standardized extract.

Who is it for
  • Adults who specifically prefer whole-leaf ginkgo
  • Users accepting variable botanical potency
  • People seeking a simple single-herb capsule
Best for
  • Whole-leaf botanical routines
  • Users not requiring standardized extract potency
  • Focused ginkgo use

Pros

  • Single-ingredient formula
  • Raw leaf amount is clearly listed
  • Freeze-dried preparation

Cons

  • Not a standardized extract
  • Active-marker yields are unknown
  • Ginkgolic-acid purity is not stated
  • Raw leaf weight is not clinically comparable

Warnings

  • Ginkgo may add to warfarin, direct oral anticoagulants, aspirin, or other antiplatelet effects and increase bleeding risk
  • Stop ginkgo before surgery or an invasive procedure when directed by the treating clinician because of its bleeding effects
  • Ginkgo may cause headache, dizziness, or digestive upset in sensitive users

Nutrient quality

69 High impact

The long-supply single-herb design is focused and avoids unrelated filler. Absent standardization makes the large raw amount difficult to judge for either effectiveness or safety.

.

Ingredient transparency

76 High impact

The whole-herb amount and preparation are disclosed without a hidden blend. Standardization, daily-use directions, and non-active ingredients remain unavailable.

.

Customer satisfaction

62 Moderate impact

The available rating is favorable and the sample is moderate. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

69 High impact

The long supply offers moderate raw-herb value. Missing standardization prevents a reliable comparison with effective ginkgo extracts.

.
Report analysis

Goals

Vision Support
Vision Support
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA+ Formula Quality

Natural astaxanthin provides targeted retinal antioxidant support and may help eye strain linked to prolonged screen use. Human evidence is promising for visual fatigue but less comprehensive than multi-nutrient macular formulas.

The algae source and substantial amount are clearly disclosed in a fat-containing softgel. The focused formula offers strong antioxidant depth but does not cover macular pigments, minerals, or omega fatty acids.

Brain Health
Brain Health
Impact
Moderate effect
B+ Goal FitD- Strength of SupportD CoverageA- Formula Quality

Ginkgo is directly relevant to cerebral circulation and cognitive performance. The full freeze-dried leaf amount is clearly stated.

Missing flavone-glycoside and terpene-lactone standardization makes the effective dose impossible to confirm. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
Moderate effect
B- Goal FitD- Strength of SupportF CoverageA- Formula Quality

Ginkgo directly targets cerebral circulation, a relevant pathway for memory and processing. The 450 mg freeze-dried amount is clear, but it is not comparable to a standardized extract without active-marker data.

Missing flavone-glycoside, terpene-lactone, and ginkgolic-acid details leave potency and purity uncertain. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Mental Focus
Impact
Moderate effect
C- Goal FitD- Strength of SupportD- CoverageA Formula Quality

Ginkgo has a plausible circulation and cognitive mechanism, but evidence for improving focus in healthy adults is inconsistent. Freeze-dried leaf is not equivalent to a standardized clinical extract, so the large stated amount is difficult to interpret.

The one-ingredient design is simple and the full leaf amount is disclosed. Ginkgo may raise bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Productivity Boost
Productivity Boost
Impact
Moderate effect
D+ Goal FitC- Strength of SupportD- CoverageB Formula Quality

Ginkgo may support some aspects of cognition, but evidence for better productivity in healthy users is inconsistent. A freeze-dried 450 mg ingredient is not clearly comparable with standardized extracts used in many trials.

The amount is disclosed, while flavonol and terpene percentages are not. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba, Freeze-Dried (Ginkgo Flavonols)
 450 mg
Adults 18–50 Vegan Kosher Dairy Free Vegetarian
Report overview
Ginkgo (Ginkgo Flavonols) · 450 mg OverallScore23
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The freeze-dried ginkgo does not disclose a standardized extract, so its active-marker strength and purity are uncertain. The full ginkgo amount is listed, but the serving is above common standardized-extract dosing while not showing that it delivers comparable active compounds. Value is difficult to judge because the low serving cost does not establish an effective standardized dose, and ginkgo can raise bleeding risk with anticoagulant or antiplatelet medicines.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones combines a substantial dose with a long supply. The missing marker percentages and ginkgolic-acid limit are the main quality gaps.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A lower serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  4. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  5. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  6. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  8. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  10. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  11. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  12. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  13. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  14. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  20. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  21. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  22. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  23. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo